These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2544747)

  • 1. [Clinical studies on the relation of abnormal growth hormone secretions to hepatic diabetes mellitus in patients with hepatocellular carcinoma].
    Kamijo K; Kawasaki K; Sato M; Yachi A
    Gan No Rinsho; 1989 Jun; 35(7):775-9. PubMed ID: 2544747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The altered plasma amino acid pattern is responsible for the paradoxical growth hormone response to the oral glucose tolerance test in liver cirrhosis.
    Martina V; Tagliabue M; Bruno GA; Bonetti G; Brancaleoni V; Meineri I; Saracco G; Zumpano E; Manieri C; Camanni F
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):175-80. PubMed ID: 9579229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus in chronic active hepatitis and cirrhosis.
    Kingston ME; Ali MA; Atiyeh M; Donnelly RJ
    Gastroenterology; 1984 Sep; 87(3):688-94. PubMed ID: 6086443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm.
    Buzzelli G; Dattolo P; Pinzani M; Brocchi A; Romano S; Gentilini P
    Am J Gastroenterol; 1993 Oct; 88(10):1744-8. PubMed ID: 8213718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease.
    Assaad SN; Cunningham GR; Samaan NA
    Metabolism; 1990 Apr; 39(4):349-56. PubMed ID: 2182971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.
    Cao J; Luo SM; Liang L; Lai J
    JPEN J Parenter Enteral Nutr; 2007; 31(6):496-501. PubMed ID: 17947606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucoregulatory hormones in hepatic cirrhosis.
    Saini JS; Pruthi HS; Naqvi S; Karnani I; Shetty KJ
    J Assoc Physicians India; 1992 Jul; 40(7):448-51. PubMed ID: 1484025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and primary hepatocellular carcinoma.
    Lawson DH; Gray JM; McKillop C; Clarke J; Lee FD; Patrick RS
    Q J Med; 1986 Oct; 61(234):945-55. PubMed ID: 2819932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
    Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and growth hormone response to an oral glucose load in Ugandan hepatocellular carcinoma patients.
    Primack A; Kajubi S
    East Afr Med J; 1974 Aug; 51(8):574-8. PubMed ID: 4371198
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
    Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
    Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.
    Masuda A; Shibasaki T; Hotta M; Suematsu H; Shizume K
    J Endocrinol Invest; 1988 Apr; 11(4):297-302. PubMed ID: 3137254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatosis and hepatocellular carcinoma risk.
    Smedile A; Bugianesi E
    Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.